Patent ID: 7645795

Claim:
A method of treating ALS in a subject who has been diagnosed with ALS, the method consisting of: (1) intravenous administration of a PC composition consisting essentially of 0.5 grams of phosphatidylcholine, followed by intravenous administration of 1.8 grams to 2.4 grams of glutathione, twice daily for 3 days in a seven day period; (2) once daily oral administration of a PC composition consisting essentially of 3.6 grams to 7.2 grams of phosphatidylcholine; (3) once or twice daily oral administration of 3 grams to 6 grams of calcium magnesium butyrate; (4) once daily oral administration of triple portions of various minerals selected from potassium, magnesium, calcium, iron, zinc, copper, chromium, manganese, molybdenum, selenium, iodine, or combinations thereof; and (5) once or twice daily oral administration of 30 ml to 60 ml of an EFA composition consisting essentially of linoleic acid and alpha-linolenic acid in a ratio of 4:1; wherein the severity of at least one ALS symptom is lessened.